Pontificia Universidad Católica de Chile / Universidad Bernardo O’Higgins
Email verificata su uc.cl
Citata da
Citata da
Innate immunity and inflammation in NAFLD/NASH
M Arrese, D Cabrera, AM Kalergis, AE Feldstein
Digestive diseases and sciences 61 (5), 1294-1303, 2016
Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling
MJ Acuña, P Pessina, H Olguin, D Cabrera, CP Vio, M Bader, ...
Human molecular genetics 23 (5), 1237-1249, 2014
Triggering and resolution of inflammation in NASH
S Schuster, D Cabrera, M Arrese, AE Feldstein
Nature Reviews Gastroenterology & Hepatology 15 (6), 349-364, 2018
Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy
MG Morales, J Gutierrez, C Cabello-Verrugio, D Cabrera, KE Lipson, ...
Human molecular genetics 22 (24), 4938-4951, 2013
Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity
C Vial, J Gutiérrez, C Santander, D Cabrera, E Brandan
Journal of Biological Chemistry 286 (27), 24242-24252, 2011
CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy
MG Morales, C Cabello‐Verrugio, C Santander, D Cabrera, ...
The Journal of pathology 225 (4), 490-501, 2011
Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease
R Fadic, V Mezzano, K Alvarez, D Cabrera, J Holmgren, E Brandan
Journal of cellular and molecular medicine 10 (3), 758-769, 2006
Angiotensin II receptor type 1 blockade decreases CTGF/CCN2‐mediated damage and fibrosis in normal and dystrophic skeletal muscles
C Cabello‐Verrugio, MG Morales, D Cabrera, CP Vio, E Brandan
Journal of cellular and molecular medicine 16 (4), 752-764, 2012
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth …
MG Morales, D Cabrera, C Céspedes, CP Vio, Y Vazquez, E Brandan, ...
Cell and tissue research 353 (1), 173-187, 2013
Renin‐angiotensin system: an old player with novel functions in skeletal muscle
C Cabello‐Verrugio, MG Morales, JC Rivera, D Cabrera, F Simon
Medicinal research reviews 35 (3), 437-463, 2015
Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy
P Pessina, D Cabrera, MG Morales, CA Riquelme, J Gutiérrez, ...
Skeletal muscle 4 (1), 1-17, 2014
Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-β and CTGF/CCN2
V Mezzano, D Cabrera, C Vial, E Brandan
Journal of Cell Communication and Signaling 1 (3-4), 205-217, 2007
Role of oxidative stress as key regulator of muscle wasting during cachexia
J Ábrigo, AA Elorza, CA Riedel, C Vilos, F Simon, D Cabrera, L Estrada, ...
Oxidative medicine and cellular longevity 2018, 2018
Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy
J Abrigo, JC Rivera, F Simon, D Cabrera, C Cabello-Verrugio
Cellular Signalling 28 (5), 366-376, 2016
Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas
MG Morales, J Abrigo, MJ Acuña, RA Santos, M Bader, E Brandan, ...
Disease models & mechanisms 9 (4), 441-449, 2016
High fat diet-induced skeletal muscle wasting is decreased by mesenchymal stem cells administration: implications on oxidative stress, ubiquitin proteasome pathway activation …
J Abrigo, JC Rivera, J Aravena, D Cabrera, F Simon, F Ezquer, M Ezquer, ...
Oxidative medicine and cellular longevity 2016, 2016
Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis
D Cabrera, J Gutiérrez, C Cabello-Verrugio, MG Morales, S Mezzano, ...
Skeletal muscle 4 (1), 6, 2014
ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis
C Riquelme, MJ Acuña, J Torrejón, D Rebolledo, D Cabrera, RA Santos, ...
PLoS One 9 (4), e93449, 2014
Andrographolide ameliorates inflammation and fibrogenesis and attenuates inflammasome activation in experimental non-alcoholic steatohepatitis
D Cabrera, A Wree, D Povero, N Solís, A Hernandez, M Pizarro, ...
Scientific reports 7 (1), 1-12, 2017
Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis
M Pizarro, N Solís, P Quintero, F Barrera, D Cabrera, ...
Liver International 35 (9), 2129-2138, 2015
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20